Hoover Financial Advisors’s Definium Therapeutics DFTX Stock Holding History

Hoover Financial Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1K	Buy	+27	New	+$1.42K	﹤0.01%	617

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Hoover Financial Advisors's DFTX Position: Q2 2021 in Review

Hoover Financial Advisors opened a new position in Definium Therapeutics (DFTX) in Q2 2021: 27 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #617 among its holdings.

155 funds tracked by Wall St. Rank hold DFTX as of Q2 2021.

Hoover Financial Advisors held 27 shares of Definium Therapeutics worth $1K as of Q2 2021.
Definium Therapeutics was a new Hoover Financial Advisors position in Q2 2021.
Definium Therapeutics made up ﹤0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #617 holding.
155 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.